32 per equity share for the year. This dividend for the year ended 31 March 2024 is subject to the approval of Members at the Annual General Meeting on 28 June 2024 and will be paid on or after 1 ...

Feb 13 (Reuters) - India's GlaxoSmithKline Pharmaceuticals (GLAX.NS), opens ... which could upend nearly $2.2 trillion in two-way annual U.S. trade, went live hours after Trump declared that ...

Market research firm Pharmatrac has revealed that India’s pharmaceutical market ... monthly value growth in March 2024. The report also revealed that GSK’s antibiotic drug Augmentin and ...

India's GlaxoSmithKline Pharma reports higher profit on strong demand for respiratory drugs India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday ...

(Reuters) - India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand for its respiratory drugs and antibiotic Augmentin. The Indian ...